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Abstract
We present the case of a 7-month-old baby with Cush-
ing’s disease due to an adrenocorticotropic hormone
(ACTH)-secreting pituitary adenoma combined with cells
producing thyreotropin-secreting hormone (TSH). In MRI
scans, a contrast-enhancing lesion was seen inside the
pituitary fossa, and it extended into the suprasellar
region. On the assumption of a pituitary adenoma, sur-
gery was performed. Corresponding with biochemical
findings, histopathological evaluation revealed an
ACTH- and TSH-producing tumor. Genetic analysis did
not demonstrate an alteration at codon 201 (Arg) and 227
(Glu). To our knowledge, this is the first case described in
a child of this age.
Introduction
Brain tumors account for 18.6% of malignant neo-
plasms and 40–50% of all solid tumors in childhood [1].
The incidence is 4–5 cases per 100,000 children per year.
However, there is considerable variation between type
and tumor location [2]. Approximately 55% of intracrani-
al tumors are located in the posterior fossa. Only 5–7% of
supratentorial lesions are located in the sellar and parasel-
lar area, most of them are craniopharyngiomas [3].
In adults, out of one million inhabitants only one will
develop an adrenocorticotropic hormone (ACTH)-pro-
ducing adenoma of the pituitary gland. There are no sta-
tistical data for the incidence of pituitary adenomas in
childhood. Only few cases are known. We describe the
case of a 7-month-old girl with Cushing’s disease due to an
ACTH-secreting pituitary adenoma combined with cells
producing thyreotropin-secreting hormone (TSH). To our
knowledge and in review of the literature, this is the first
case described.
Case Report
We present the case of a 7-month-old baby, the twin of a normal
sister and healthy parents. Five months after birth, the parents
noticed progressive obesity and fatigue. The baby was less active, did
not fixate on objects and frequently cried. The mother presented the
baby to an ophthalmologist who diagnosed a papilledema and recom-
mended neurosurgical evaluation.
Physical Examination
On admission the child showed diminished vigilance with re-
duced spontaneous movements. Compared to her twin sister (6.5 kg)
a weight gain of 1 kg was noticed. The examination revealed typical
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Fig. 1, 2. Magnetic resonance imaging of the pituitary adenoma. T1-
weighted coronal (1) and sagittal (2) showing a 2 ! 2 ! 3 cm mea-
suring, contrast enhancing lesion with intra- and suprasellar exten-
sion.
Fig. 3, 4. Postoperative coronal (3) and sagittal (4) MRI-slices.
Complete tumor removal using a pterional approach.
cushingoid features including a moon face, truncal obesity and buffa-
lo hump. There were no clinical signs and symptoms of hyperthyroid-
ism. Otherwise, the physical evaluation was normal including skin
development and pigmentation.
Biochemical Investigations
Preoperatively, morning blood cortisol was initially 1,002 nmol/l
(normal value, NR: 80–630 nmol/l); the ACTH value was moderate-
ly elevated (24.1 pmol/l, NR: 3.5–4.9 pmol/l). Prolactin, human
growth hormone (HGH), aldosterone, insulin-like growth factor 1
(IGF-1) and human chorionic gonadotropin were within physiologi-
cal limits. Testosterone could not be detected. Basal TSH was
1.28 mU/l (NR: 0.35–4.00 mU/l). After stimulation with TRH, a
normal increase in TSH up to 8.16 mU/l was found. Blood count and
serum electrolytes showed normal values.
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Fig. 5, 6. Histopathological and immuno-
histological evaluation showed tumor cells
with irregular nuclei and chromatin filling.
The cytoplasma stained weakly for a baso-
philic or eosinophilic compound (5). TSH
and ACTH antibodies were positive in up to
5% of tumor cells (6).
Radiographs and MRI Scans
Plain X-ray films of the skull showed an excavated sella turcica
T2-weighted magnetic resonance images presented an intra- and
suprasellar isointense lesion measuring 2 ! 2 ! 3 cm. In the
T1-weighted scans, hypo- and hyperintense plaques were seen. After
application of gadolinium, a contrast-enhancing lesion inside the
pituitary fossa was identified that extended into the suprasellar
region. The optic chiasma and prechiasmatic parts of the optic nerves
were compressed by the tumor. Parts of the mass lesion surrounded
both internal carotid arteries. The differential diagnosis included a
pituitary tumor or an optic glioma (fig. 1–4).
Surgical Treatment
On the assumption of a pituitary adenoma, surgery was per-
formed. A pterional approach was selected because of the patient’s
age and the suprasellar extension of the lobulated tumor. Intraopera-
tively, the optic nerves and internal carotid arteries were exposed.
The tumor compressed and displaced the optic chiasm and led to an
elongation of the optic nerves. The tumor was completely removed,
leaving the nerves and vessels unaffected.
Histopathological Evaluation
Solid tissue with rosettes and tubular structures was found. The
tubular cell components consisted of spherical, protein content and
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calcification similar to Crooke’s hyaline. Tumor cells showed irregu-
lar nuclei with chromatin filling. The cytoplasm did not show a
strong basophilic or eosinophilic compound. Immunohistological
staining with TSH and ACTH antibodies was positive in up to 5% of
tumor cells. No expression of follicle-stimulating hormone, luteiniz-
ing hormone (LH), prolactin or HGH was found (fig. 5,6).
The histopathological evaluation was in accordance with a pitu-
itary adenoma with low quantities of ACTH and TSH secretion.
Genetic Analysis
Point mutations of the ·-subunit of GTP-binding proteins (Gs·)
are related to the development of growth hormone (GH)-secreting
pituitary adenomas in 30–45% of adult patients [4]. We examined
the child’s tumor DNA in order to assess a relationship between the
ACTH-secreting adenoma and Gs· mutations. DNA was prepared
using standard techniques of cell lysis and DNA separation. PCR
cycles were carried out with following primer pairs: exons 7–8
(466 bp) 5)-TGAGCCTGACCTTGTAGAGAGACACA-3) and 5)-
GGTTATTCCAGAGGGACTGGGGTGAA-3), as well as exons
9–11 (698 bp) 5)-GACATTCACCCCAGTCCCTCTGGAAT-3), re-
spectively, 5)-AGAACCACCGCAATGAACAGCC-3) and exons
7–10 5)-GCGCTGTGAACACCCCACGTGTCT-3) and 5)-CGC-
AGGGGGTGGGCGGTCACTCCA-3).
No alterations at codon 201 (Arg) and 227 (Glu) were detected.
The results correspond with the gsp-negative findings in children
with GH-producing tumor cells [5].
Postoperative Course and Follow-Up
The child rapidly recovered from the surgical intervention. A
cerebrospinal fluid leak had been treated by wound reinforcement.
Six weeks after tumor removal, no ACTH production was detectable.
Four days after surgery, a very low TSH of 0.04 mU/l in the presence
of low normal levels of peripheral thyroid hormones (triiodo-
thyronine 1.26 nmol/l, NR: 1.10–3.20 nmol/l; tetraiodothyronine
94 nmol/l, NR: 60–160 nmol/l) were detected, suggesting secondary
hypothyroidism. Cortisol and thyroxin had to be substituted. Other
hormones of the anterior lobe of the pituitary and adrenal glands
such as HGH (0.25–0.42 ng/ml), aldosterone (209–484 pmol/l) and
IGF-1 (14.0 ng/ml), were decreased, indicating temporary insuffi-
cient pituitary production.
At the 1-year follow-up the child was still behind her twin sister in
neurological development. Her vision was still partly impaired, and
the baby’s weight corresponded to the chronological age.
Discussion
To our knowledge, this is the first case report on a child
of this age with a combined ACTH- and TSH-producing
pituitary adenoma. In 70% of pediatric patients, endoge-
nous Cushing’s syndrome is caused by adrenal tumors
with a distinct female predominance, and they are mostly
due to pituitary adenomas. Cushing’s disease affects chil-
dren of all ages [6]. However, after the age of 7 years, pitu-
itary tumors are the primary reason for development of
Cushing’s syndrome, and the sex difference disappears
[7, 8].
Other causes are exceedingly rare, including primary
pigmented nodular adrenocortical disease (PPNAD) of
the adrenal glands and ectopic ACTH production by a
nonpituitary tumor [6, 9–14].
Houwen et al. [7] presented 4 young patients between 5
and 14 years with Cushing’s disease related to ACTH
overproduction caused by PPNAD. A study by Thomas et
al. [9] described 2 out of 18 children with Cushing’s syn-
drome who developed a secondary pituitary tumor in-
duced by bilateral nodular dysplasia. Though they are in
second place after adrenal tumors in inducing cortisol
overproduction, ACTH-secreting pituitary lesions are
rare in childhood. In a 33-year survey, 10 children, aged
1–7 years, were reported with hypercortisolism due to
pituitary adenomas [8]. No additional hormone overpro-
duction was documented. Maeder et al. [15] presented the
CT and MRT findings of a 12-month-old girl with a large
tumor arising from the sella turcica. The histology re-
vealed an ACTH-secreting pituitary adenoma.
The coincidence of ACTH-producing pituitary adeno-
mas with additional hormone release in childhood has
been reported in only a few cases. Puchner et al. [16]
treated a 10-year-old boy by surgery. A corticotropin-
releasing hormone-secreting intrasellar gangliocytoma
combined with an ACTH-producing pituitary tumor was
removed. A case report by Faggiano et al. [17] described
sexual precocity in a 4.5-year-old boy due to hypersecre-
tion of LH and prolactin. In our patient, the immunohis-
tochemical staining of tumor cells for TSH was not
reflected by an elevation of serum TSH or clinical signs of
hyperthyroidism, suggesting that only a minority of tumor
cells actually secreted TSH.
The symptoms and clinical findings are similar in both
children and adults. In our case the leading symptoms
were loss of activity and fixation, requiring surgical inter-
vention.
Pituitary tumors may occur as part of the Carney com-
plex, familial multiple neoplasia and lentiginosis syn-
drome. In the presented child, there was no clinical evi-
dence for the Carney complex [18], as myxomas, spotty
pigmentation and schwannomas were missing. The par-
ents were healthy, hence an inherited disorder seemed to
be unlikely. GH-secreting pituitary adenoma can express
a Gs· mutation in adult patients [4]. In children, one
study showed Gs· modifications. Activating sites are
found at codon 201 (Arg) and 227 (Glu) of exons 8 and 9,
producing the gsp oncogene [5]. Genetic analysis of the
child’s DNA did not show oncogene mutations of the Gs·
gene.
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The postoperative course was typical for a complete
removal of an ACTH-producing adenoma. Weight reduc-
tion could be seen, and cortisone substitution was neces-
sary. Follow-up MRI scans did not identify any residual
tumor masses. In the 1-year postoperative observation
period, the child’s development was still delayed.
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